| "The DNCB-method in malignant melanoma is yet in the experimental stage and is not recommended for general use in practice." | ( Djawari, D; Weidner, F, 1979) |
| "Malignant melanoma is rather uncommon in India." | ( Reddy, CR; Satyanarayana, BV; Sundareshwar, B; Yellama, A, 1976) |
| "As the frequency of malignant melanoma is increasing and, as a great proportion of the melanomata are localized to the extremities, these patients should be offered hyperthermic regional perfusion on removal of the primary tumour and also if recurrence occurs." | ( Andersson, AP; Drzewiecki, KT, 1992) |
| "Malignant melanoma is one of the most malignant froms of cancer, for which the prognosis is still very grave." | ( Ikegawa, S; Ishihara, K, 1985) |
| "Malignant melanoma is generally considered as a hormone-independent tumour." | ( Mouridsen, HT; Pedersen, L; Rose, C, 1985) |
| "Malignant melanoma is common among the whites of South Africa." | ( Isaacson, C; Spector, I, 1987) |
| "Primary cutaneous malignant melanomas are generally divided into 3 separate clinico-pathological variants, lentigo maligna melanoma (LMM), superficial spreading melanoma (SSM), and nodular melanoma (NM)." | ( Søndergaard, K, 1983) |
| "Malignant melanoma is appropriate for this investigative and diagnostic technique because of its superficial localization." | ( Dobiás, J; Dobrota, D; Kasparová, S; Liptaj, T; Péc, J; Péc, M; Prónayová, N; Salon, F, 1995) |
| "Malignant melanoma is among the malignant tumors which still have the poorest prognosis." | ( Asano, K; Ishihara, K; Yamazaki, N, 1993) |
| "Nonocular malignant melanoma is a rare but lethal disease increasing in incidence and mortality in western countries with improved survival if diagnosed and treated early." | ( Gujarathi, M; Joshi, S; Jussawalla, DJ; Krishnamurthy, S; Yeole, B, 1994) |
| "The incidence of malignant melanoma is much lower in Japanese than in Caucasians, and the commonest type of melanoma in Japanese is acral lentiginous melanoma (ALM)." | ( Kato, T; Kumasaka, N; Suetake, T; Sugiyama, Y; Tabata, N; Tagami, H, 1995) |
| "Malignant melanoma is a relatively uncommon cancer of increasing incidence." | ( Alonso, O; Bazzano, C; Delgado, L; Espasandin, J; Lago, G; Martinez, M; Mut, F; Saadoun, A; Touya, E, 1996) |
| "A case of malignant melanoma is presented, in which I-123 IMP scintigraphy was useful to visualize the bone metastases." | ( Fukunaga, M; Morita, K; Otsuka, N; Sone, T, 1996) |
| "Human malignant melanoma is notoriously resistant to pharmacological modulation." | ( Artuc, M; Fichtner, I; Henz, BM; Jurgovsky, K; Kern, MA; Kolde, G; Makki, A; Nürnberg, W; Pahl, HL; Rosenbach, T; Schadendorf, D; Stüting, S; von Stebut, E; Worm, M, 1996) |
| "Because malignant melanoma is a highly malignant neoplasm, correct diagnosis and appropriate treatment are essential to improve the prognosis." | ( Saida, T, 1997) |
| "Human malignant melanoma is characterised by unresponsiveness to conventional chemotherapy." | ( Berger, W; Elbling, L; Hauptmann, E; Kokoschka, EM; Micksche, M; Vetterlein, M, 1997) |
| "Malignant melanoma is a prime example of cancers that respond poorly to various treatment modalities including chemotherapy." | ( Brown, BD; Bryan, RN; Eichler, HG; Jansen, B; Müller, M; Pehamberger, H; Schlagbauer-Wadl, H; van Elsas, A; Wolff, K, 1998) |
| "Primary anorectal malignant melanoma is a fairly uncommon but highly malignant disease." | ( Haneji, H; Katayama, N; Kurihara, T; Nakatsuka, H; Ohmoto, T; Ojima, Y; Sadamoto, S; Taniyama, K, 1999) |
| "Malignant melanoma is well known for its primary unresponsiveness to chemotherapy." | ( Christmann, M; Dietel, M; Kaina, B; Kern, MA; Lage, H; Pick, M; Schadendorf, D, 1999) |
| "Cutaneous malignant melanoma is a life-threatening cancer with poor prognosis due to a high metastasis potential." | ( Bush, JA; Ho, VC; Li, G, 2000) |
| "Although malignant melanomas are often associated with cytotoxic lymphocyte infiltration, these cells are largely ineffective in inducing tumour cell kill, indicating that the melanoma cells have protective mechanisms." | ( Barral, AM; Källström, R; Rosén, A; Sander, B, 2000) |
| "Small cell malignant melanoma is postulated to be a distinct histopathological entity and a rare variant of naevoid melanoma." | ( Blessing, K; Coburn, P; Grant, JJ; Husain, A; Kennedy, MM; Sanders, DS, 2000) |
| "Malignant melanoma is resected with curative intent in 80-85% of the patients." | ( Franke, W; Neumann, NJ; Ruzicka, T; Schulte, KW, 2001) |
| "Malignant melanoma is increasing in frequency at a rapid rate in the United States." | ( Didolkar, MS; Eckardt, JR; Flaherty, LE; Samlowski, W; Sondak, VK; Taylor, SA; Unger, JM; Whitehead, RP, 2001) |
| "Malignant melanoma is a cancer whose incidence is rising rapidly, but the mechanism by which normal melanocytes become malignant in vivo is still little understood." | ( Geissinger, E; Schartl, M; Troppmair, J; Weisser, C; Wellbrock, C, 2002) |
| "Primary mucosal malignant melanomas are rare." | ( Cansiz, H; Karakullukçu, B; Ozek, H; Oztürk, O, 2001) |
| "Malignant melanoma is a skin tumour, which carries a very unfavourable prognosis." | ( Arndt, R; Hartleb, J, 2001) |
| "Malignant melanoma is heterogeneous in terms of its biological, immunological and metastatic properties, and melanoma cells exhibit a polymorphous expression of tumour markers." | ( Enk, CD; Gimon, Z; Hochberg, M; Lotem, M; Shiloni, E, 2002) |
| "Malignant melanoma is a tumor that responds poorly to a variety of apoptosis-inducing treatment modalities, such as chemotherapy." | ( Heere-Ress, E; Jansen, B; Lucas, T; Monia, BP; Pehamberger, H; Schlagbauer-Wadl, H; Thallinger, C; Wacheck, V; Wolff, K, 2002) |
| "The incidence of malignant melanoma is rising; it now has an incidence of ten per 100 000 per annum in the UK." | ( Hill, AD; O'Higgins, NJ; Prichard, RS; Skehan, SJ, 2002) |
| "Malignant melanoma is a rare malignant tumor arising within the melanocytes of the skin." | ( Jang Kim, S; Ju Kim, I; Ki Kim, Y; Won Seok, J, 2002) |
| "Malignant melanoma is rapidly increasing in the United States." | ( Chapman, RA; Doolittle, GC; Flaherty, LE; Hammond, N; Klein, CE; Kraut, EH; Mills, GM; Sondak, VK; Unger, JM; Whitehead, RP, 2002) |
| "Malignant melanoma is one of the tumors which may metastasize to the thyroid gland." | ( Aigner, RM; Nicoletti, R; Schwarz, T; Wolf, G, 2002) |
| "Malignant melanoma is one of those malignancies with worldwide increasing incidence." | ( Aigner, RM; Richtig, E; Schwarz, T, 2002) |
| "Malignant melanoma is a tumor known for its uncontrollable growth and aggressive metastatic behavior." | ( Limonta, P; Montagnani Marelli, M; Moretti, RM; Van Groeninghen, JC, 2002) |
| "Anorectal malignant melanoma is an uncommon tumour." | ( Fierlbeck, G; Metzger, S; Ulmer, A, 2002) |
| "Malignant melanoma is the most common tumor metastatic to the GI tract." | ( Horvath, W; Khosrowshahi, E, 2002) |
| "Anorectal malignant melanoma is relatively rare and its prognosis is very poor because of distant metastasis via the blood or lymphatic vessels." | ( Ebisui, C; Fujimoto, T; Fukuchi, N; Izawa, H; Kanai, T; Sakita, I; Souma, I; Yoshida, T, 2002) |
| "Malignant melanoma is one of the most rapidly increasing cancer types, and patients with metastatic disease have a very poor prognosis." | ( Bitisik, O; Camlica, H; Dalay, N; Duranyildiz, D; Kurul, S; Tas, F, 2003) |
| "Taking a biopsy of malignant melanoma is generally contraindicated because of the high risk of inducing metastasis." | ( Abe, K; Aoki, T; Hayashi, M; Kitamura, K; Koyanagi, Y; Mori, M; Saito, H; Sato, S; Tsuchida, A; Umezu, K; Yamagishi, T, 2003) |
| "The progression of malignant melanoma is characterized by overexpression of a number of matrix metalloproteinases (MMPs), especially MMP-2, which play a critical role in the degradation of basement membranes and the extracellular matrix." | ( Badary, OA; Drevs, J; Esser, N; Fichtner, I; Hamada, FM; Kratz, F; Mansour, AM; Unger, C, 2003) |
| "Malignant melanoma is rare before puberty." | ( NEWMAN, BA, 1957) |
| "Malignant melanoma is rare before puberty." | ( NEWMAN, BA, 1957) |
| "Malignant melanoma is rare before puberty." | ( NEWMAN, BA, 1957) |
| "Malignant melanoma is rare before puberty." | ( NEWMAN, BA, 1957) |
| "Malignant melanoma is one of the most worrisome tumors in terms of epidemiology, and incidence is increasing." | ( Khayat, D; Meric, JB; Rixe, O, 2003) |
| "Malignant melanoma is considered to be a chemotherapy-refractory tumour, and the commonly used anticancer drugs do not seem to modify the prognosis of metastatic disease." | ( Cannavò, E; D'Atri, S; Falchetti, R; Fuggetta, MP; Lanzilli, G; Ravagnan, G; Tricarico, M; Zambruno, G, 2004) |
| "Mucosal malignant melanomas are rare lesions, and they have different characteristics from their cutaneous counterparts." | ( Cansiz, H; Güzel, MZ; Karakullukçu, B; Ozek, H; Oztürk, O, 2005) |
| "Metastatic malignant melanoma is an extremely aggressive cancer, with no currently viable therapy." | ( Alworth, WL; Fitzpatrick, JE; Ghosh, R; Kumar, AP; Nadiminty, N; Slaga, TJ, 2005) |
| "Osteoid malignant melanoma is a rare type of melanoma described in humans and dogs with some areas of bone differentiation." | ( Estrada, M; Fontaine, JJ; Lagadic, M; Maliver, P; Manin, S; Mialot, M, 2004) |
| "Anorectal malignant melanoma is a rare tumor and there is no consensus on whether aggressive or local management is more appropriate." | ( Cemazar, M; Jancar, B; Rudolf, Z; Sersa, G; Snoj, M, 2005) |
| "Malignant melanoma is the seventh most common newly diagnosed cancer among Americans." | ( Alavi, A; Kumar, R, 2005) |
| "Malignant melanoma is well known for its poor response to chemotherapy, radiotherapy and its susceptibility to immunotherapy." | ( Jović, V; Konjević, G; Radomirović, V; Spuzić, I, 2002) |
| "Malignant melanoma is the most aggressive form of skin cancer and has proven to be highly resistant to conventional chemotherapy." | ( Niemetz, A; Pützer, BM; Racek, T; Schultz, J; Soengas, MS; Tuve, S, 2006) |
| "Malignant melanoma is the third most common skin cancer in the United States." | ( Ivry, GB; Ogle, CA; Shim, EK, 2006) |
| "Malignant melanomas are characterized by a high intrinsic resistance to chemotherapy." | ( Baker, B; Engel, JB; Halmos, G; Keller, G; Nagy, A; Schally, AV, 2006) |
| "Human malignant melanoma is a highly aggressive form of cancer; the 5-year survival rate in patients with stage III or IV disease is <5%." | ( Ekmekcioglu, S; Fok, JY; Mehta, K, 2006) |
| "Malignant melanoma is highly refractory to conventional radio- and chemotherapy." | ( Hei, TK; Ivanov, VN, 2006) |
| "Malignant melanoma is particularly resistant to conventional chemotherapy and radiotherapy." | ( Benassi, L; Bernardi, C; Bertazzoni, G; Coppi, A; Costi, MP; Gelain, A; Giannetti, A; Giudice, S; Gualdi, G; Magnoni, C; Rossi, T; Venturelli, A, 2007) |
| "Malignant melanoma is a common and frequently lethal disease." | ( Bosenberg, M; Bradbury, CM; Curley, DP; Duraisamy, S; Hobbs, C; Muthusamy, V; Nelson, B, 2006) |
| "Malignant melanoma is one of the most aggressive skin cancer and chemotherapeutic agents currently in use are still unsatisfactory." | ( Delogu, G; Dettori, MA; Fabbri, D; Loi, M; Mura, ME; Pagnan, G; Palmieri, G; Pisano, M; Ponzoni, M; Rozzo, C; Tilocca, MG, 2007) |
| "Metastatic malignant melanoma is a devastating disease with a poor prognosis." | ( Buzney, E; Fuhlbrigge, RC; Kupper, TS; Munoz, KN; Weishaupt, C, 2007) |
| "Malignant melanoma is a highly aggressive tumor which frequently resists chemotherapy, therefore, the search for new agents for its treatment is of great importance." | ( Bergman, M; Cohen, Y; Dovrat, S; Gottlieb, H; Grossman, S; Rozenblat, S, 2008) |
| "Malignant melanoma is a rare pathology: 1-4% of all melanomas occur before the age of 20 and 0." | ( Bouali, O; Galinier, P; Guitard, J; Lamant, L; Salazard, B, 2009) |
| "Cutaneous malignant melanoma is an aggressive type of skin cancer which causes disproportionate mortality in young and middle-aged adults." | ( Casanova, JM; Dolcet, X; Egido, R; Llobet, D; Llombart, A; Marti, RM; Matias-Guiu, X; Pérez de Santos, AM; Schoenenberger, JA; Soria, X; Sorolla, A; Vilella, R; Yeramian, A, 2008) |
| "Malignant melanoma is a potentially fatal skin cancer that is increasing in incidence." | ( Dutz, JP; Najar, HM, 2008) |
| "Malignant melanoma is one of the most lethal cancers." | ( Chammas, R; Donatti, L; Luvizon, AC; Mercadante, AF; Nakao, LS; Naliwaiko, K; Zanata, SM, 2008) |
| "Malignant melanoma is the most deadly form of skin cancer due to its highly metastatic nature." | ( Amin, S; Desai, D; Huh, SJ; Madhunapantula, SV; Robertson, GP; Sharma, A, 2008) |
| "Human malignant melanoma is notoriously resistant to currently available pharmacological modulation." | ( Geng, S; Li, X; Li, Z; Liu, Y; Pan, M; Peng, Z; Ren, J; Xiao, S, 2009) |
| "Twenty to 30% of malignant melanomas are associated with melanocytic nevi; however, sometimes it is difficult to distinguish the melanoma from the nevus by routine histology." | ( Kamino, H; Tam, S; Tapia, B; Toussaint, S, 2009) |
| "Malignant melanomas are highly resistant to chemotherapy." | ( Belohlavek, C; Christmann, M; Jöst, E; Kaina, B; Lennerz, V; Naumann, SC; Roos, WP; Schmidt, CW, 2009) |
| "Metastatic malignant melanoma is an incurable malignancy with extremely poor prognosis." | ( Erickson, LA; Farley, DR; Flotte, TJ; Jakub, JW; Kottschade, LA; Markovic, SN; McWilliams, RR; Olivier, KR; Pittelkow, MR; Pulido, JS; Quevedo, JF; Schild, SE; Sekulic, A; Stoian, I; Tran, NV; Vile, RG; Vuk-Pavlovic, S; Weenig, RH; Wiseman, GA, 2009) |
| "Malignant melanoma is one of the most aggressive human neoplasms and its incidence is still increasing." | ( Weinlich, G, 2009) |
| "Malignant melanoma is a highly metastatic cutaneous cancer and typically refractory to chemotherapy." | ( Mousavi-Shafaei, P; Zangemeister-Wittke, U; Ziaee, AA, 2009) |
| "Malignant melanomas are generally drug resistant and have a very poor prognosis." | ( Andersson, Y; Fodstad, Ø; Risberg, K, 2009) |
| "Malignant melanoma is resistant to almost all conventional forms of chemotherapy." | ( Akbari, M; Andrew, SE; Felton, KE; Keuling, AM; Parker, AA; Tron, VA, 2009) |
| "Malignant melanomas are intrinsically resistant to many conventional treatments, such as radiation and chemotherapy, for reasons that are poorly understood." | ( Cardarelli, CO; Chen, KG; Gottesman, MM; Hearing, VJ; Lai, B; Leapman, RD; Valencia, JC; Vieira, WD; Zhang, G, 2009) |
| "Malignant melanoma is a highly aggressive and drug-resistant cancer." | ( Aurelian, L; Colunga, AG; Laing, JM, 2010) |
| "The incidence of malignant melanoma is increasing at an alarming rate, doubling in women and growing by more 300% in men during the past 25 years." | ( Stadelmann, WK, 2010) |
| "Malignant melanoma is one of the most aggressive human neoplasms which develop from the malignant transformation of normal epithelial melanocytes and share the lineage with retinal cells." | ( Bazhin, AV; Dikov, B; Eichmüller, SB; Philippov, PP; Schadendorf, D; Tambor, V, 2010) |
| "The incidence of malignant melanoma is increasing at an alarming rate globally." | ( Chaudhuri, P; Sengupta, S; Soni, S, 2010) |
| "Primary pulmonary malignant melanoma is rare (0." | ( Bonnichon-Py, A; Foehrenbach, H; Le Floch, H; Mairovitz, A; Margery, J; Marotel, C; Pons, F; Rivière, F; Salles, Y; Staub, E; Vaylet, F, 2010) |
| "Malignant melanoma is one of the most lethal and aggressive human malignancies." | ( Jiang, G; Liu, YQ; Mao, LJ; Pei, DS; Wei, ZP; Zheng, JN, 2010) |
| "Malignant melanoma is an aggressive skin cancer with no effective therapies currently approved for advanced disease." | ( Binder, M; Erasim, C; Harmankaya, K; Hoos, A; Ibrahim, R; Koelblinger, C; Pehamberger, H, 2011) |
| "Malignant melanoma is rising faster in incidence than any other malignancy." | ( Boasberg, P; Hamid, O; O'Day, S, 2010) |
| "Malignant melanoma is a highly aggressive tumor that frequently resists chemotherapy, so the search for new agents for its treatment is of great importance." | ( Castello, G; De Marino, S; Festa, C; Ialenti, A; Ianaro, A; Iorizzi, M; Napolitano, M; Panza, E; Tersigni, M; Zollo, F, 2011) |
| "Disseminating malignant melanoma is a lethal disease highly resistant to radio- and chemotherapy." | ( Bao, W; Chen, M; Issaeva, N; Kumar, R; Selivanova, G; Spinnler, C; Strömblad, S; Thullberg, M; Zhao, X, 2011) |
| "Malignant melanoma is the most malignant of skin tumor." | ( Jiang, G; Liu, YQ; Pei, DS; Wei, ZP; Xin, Y; Zheng, JN, 2011) |
| "Malignant melanoma is the deadliest form of skin cancer, known for its drug resistance and high metastatic potential." | ( Amin, S; Chung, CY; Desai, D; Madhunapantula, SV; Robertson, GP, 2011) |
| "Malignant melanoma is well known for its propensity to spread to unpredictable sites." | ( Mudun, A; Ozkan, G; Sanli, Y; Turkmen, C; Yegen, G, 2011) |
| "Human malignant melanoma is highly resistant to chemotherapy and current immunotherapeutic approaches induce long term remission only in the minority of patients." | ( Busse, A; Keilholz, U, 2011) |
| "Cutaneous malignant melanoma is an aggressive disease of poor prognosis." | ( Angel, P; Blaber, M; Blaber, SI; Hess, J; Krenzer, S; Mauch, C; Peterziel, H, 2011) |
| "Malignant melanoma is an aggressive cancer of pigment-producing cells, derivates of the neural crest." | ( Heneberg, P, 2011) |
| "The incidence of malignant melanoma is growing rapidly worldwide and there is still no effective therapy for metastatic disease." | ( Li, W; Melton, DW, 2012) |
| "The incidence of malignant melanoma is rising faster than that of any other cancer in the United States." | ( Barkey, NM; De Silva, CR; Gillies, RJ; Hruby, VJ; Josan, JS; Morse, DL; Sill, KN; Tafreshi, NK; Vagner, J, 2011) |
| "Malignant melanoma is known by its rapid progression and poor response to currently applied treatments." | ( Sevko, A; Umansky, V, 2012) |
| "Malignant melanoma is a disease with high mortality rate caused by rapid metastasis." | ( Ciołczyk-Wierzbicka, D; Gil, D; Laidler, P, 2012) |
| "Malignant melanoma is a deadly type of metastatic skin cancer with increased incidence over the past 30 years." | ( Arruda, DC; Farias, CF; Favero, OA; Ferreira, MJ; Figueiredo, CR; Girola, N; Lago, JH; Massaoka, MH; Matsuo, AL; Romoff, P; Scutti, JA; Travassos, LR, 2012) |
| "Malignant melanoma is a relatively rare but potentially aggressive tumor in children and adolescents." | ( Abasq, C; Charles-Pétillon, F; Coat, C; De Braekeleer, M; Marcorelles, P; Quintin-Roué, I; Talagas, M; Uguen, A, 2012) |
| "The incidence of malignant melanoma is increasing worldwide, despite our best efforts in prevention and early detection." | ( Arenbergerová, M; Puzanov, I, 2012) |
| "Malignant melanoma is difficult to treat due to its resistance to chemotherapeutic regimens." | ( Adams, E; Hailey, S; McLane, MA; Penn, R; Wong, A, 2013) |
| "Metastatic malignant melanoma is highly resistant to chemotherapy, and the average survival rate is under 1 year." | ( Anvekar, RA; Asciolla, JJ; Belbin, G; Chipuk, JE; Elkholi, R; Floros, KV; Izadmehr, S; Lopez-Rivera, E; Sikora, AG, 2012) |
| "The prognosis for malignant melanoma is poor; therefore, new diagnostic methods and treatment strategies are urgently needed." | ( Inui, M; Morita, H; Murata, T; Okumura, K; Shimizu, K; Tagawa, T, 2013) |
| "Invasive malignant melanoma is the most common fatal form of skin cancer." | ( Glatz, K; Itin, P; Ivanova, K; Nicolas, G; Zippelius, A, 2012) |
| "Malignant melanoma is one of the most lethal and aggressive human malignancies." | ( Cheng, Q; Jiang, AJ; Jiang, G; Li, LT; Tian, H; Zheng, JN, 2013) |
| "Malignant melanoma is a highly-aggressive type of malignancy with considerable metastatic potential and frequent resistance to cytotoxic agents." | ( Brors, B; Enk, A; Helmbold, P; Penzel, R; Schirmacher, P; Skorokhod, A, 2013) |
| "The incidence of malignant melanoma is increasing annually." | ( Nathan, PD; Shaw, HM, 2013) |
| "Malignant melanoma is notorious for its high resistance to chemotherapy, and new anti-melanoma drugs are urgently needed." | ( Albeck, A; Lellouche, MB; Levinger, S; Sharabi-Ronen, Y, 2014) |
| "Malignant melanoma is the most aggressive form of skin cancer." | ( Cao, Z; Guo, P; Liu, R; Pan, Y; Yang, P; Zhang, G; Zhou, Q, 2013) |
| "Malignant melanoma is a highly aggressive tumor with increasing incidence and high mortality." | ( Dundr, P; Dvořák, P; Dvořánková, B; Kodet, O; Krajsová, I; Krejčí, E; Lacina, L; Smetana, K; Štork, J; Szabo, P, 2013) |
| "Malignant melanomas are characterized by the ability of early metastatic dissemination to regional lymph nodes and the detection of sentinel lymph node metastases serves as an important prognostic parameter." | ( Bianchini, F; Calorini, L; Contena, C; Peppicelli, S; Tombaccini, D, 2013) |
| "Human malignant melanoma is one of the most aggressive forms of skin cancer with an exceptionally bad prognosis." | ( Lázár, V, 2013) |
| "The incidence of malignant melanoma is continuously rising, but the therapy of advanced melanoma remains insufficient." | ( Liszkay, G, 2013) |
| "Malignant melanoma is refractory to various chemotherapeutics including antitubulin agents such as paclitaxel." | ( Akasaka, T; Inoue, T; Kasai, S; Maesawa, C; Masuda, T; Shibazaki, M; Takahashi, K; Watanabe, A; Yasuhira, S, 2013) |
| "Canine malignant melanomas are highly aggressive and fatal neoplasms." | ( Bonkobara, M; Hiroi, T; Ito, K; Iwata, T; Kobayashi, M; Kuroki, S; Kuroki, T; Mori, K; Nakagawa, T; Ono, K; Ozawa, Y; Sasaki, Y; Tetsuka, M; Washizu, T; Yamamoto, H, 2013) |
| "Malignant melanoma is an aggressive skin cancer and it is reported to be the most treatment-resistant human cancer." | ( Aliwaini, S; Blanckenberg, A; Mapolie, S; Prince, S; Swarts, AJ, 2013) |
| "The risk for malignant melanoma is higher than expected in Parkinson's disease (PD)." | ( Augustine, EF; Auinger, P; Constantinescu, R; Elm, J; Khadim, L; Kieburtz, K; Sharma, S, 2014) |
| "Malignant melanoma is highly aggressive, and always resistant to conventional chemo-radiotherapy, which results in poor prognosis." | ( Cui, H; Liu, Y; Yi, L; Zhang, Y; Zhu, S, 2014) |
| "Malignant melanoma is responsible for approximately 75% of skin cancer-related deaths." | ( Afaq, F; Athar, M; Ballestas, ME; Elmets, CA; Katiyar, SK; Pal, HC; Sharma, S; Strickland, LR, 2014) |
| "Malignant melanoma is the most aggressive and deadliest form of skin cancer due to its highly metastatic potential, which calls for new and improved therapies." | ( Berge, G; Camilio, KA; Ravuri, CS; Rekdal, O; Sveinbjørnsson, B, 2014) |
| "Malignant melanoma is characterized by the development of chronic inflammation in the tumor microenvironment, which leads to a strong immunosuppression associated with a rapid tumor progression." | ( Bazhin, AV; Shevchenko, I; Umansky, V; Utikal, J, 2014) |
| "Malignant melanoma is one of the most aggressive forms of cancer and its incidence is rapidly increasing." | ( Alili, L; Brenneisen, P; Das, S; Gupta, A; Karaman, E; Sack, M; Seal, S, 2014) |
| "Malignant melanoma is the most lethal form of skin cancer, with a high propensity to metastasize to the brain." | ( Bjerkvig, R; Dale, HA; Daphu, I; Horn, S; Skaftnesmo, KO; Spriet, E; Stieber, D; Thorsen, F; Varughese, JK, 2014) |
| "Malignant melanoma is the most deadly type of skin cancer." | ( Costa, VM; Diniz, C; Fresco, P; Soares, AS, 2015) |
| "The incidence of malignant melanoma is increasing worldwide." | ( Berrocal, A; Cabañas, L; Espinosa, E; Fernández-de-Misa, R; Martín-Algarra, S; Martínez-Cedres, JC; Ríos-Buceta, L; Rodríguez-Peralto, JL, 2014) |
| "Malignant melanoma is an aggressive form of skin cancer with limited effective therapeutic options." | ( Anant, S; Jensen, RA; Kaushik, G; Kwatra, D; Mammen, JM; Subramaniam, D, 2014) |
| "Malignant melanoma is the deadliest form of skin cancer; the treatment of advanced and recurrent forms remains a challenge." | ( Block, NL; Cai, RZ; Klukovits, A; Krishan, A; Popovics, P; Rick, FG; Schally, AV; Szalontay, L; Vidaurre, I; Zarandi, M, 2014) |
| "Malignant melanoma is the most aggressive and deadly form of skin cancer." | ( Jiang, G; Li, RH; Liu, YQ; Sun, C; Zheng, JN, 2014) |
| "Malignant melanoma is an aggressive and deadly form of skin cancer, and despite recent advances in available therapies, is still lacking in completely effective treatments." | ( Aziz, F; Fu, YS; Liu, JW; Shan, X; Wang, XQ; Yan, Q, 2014) |
| "Malignant melanoma is a form of skin cancer associated with significant mortality once it has spread beyond the skin." | ( Apalla, Z; Chan, AW; Kyrgidis, A; Mocellin, S; Pilati, P; Tzellos, T, 2014) |
| "Malignant melanoma is an aggressive tumor with poor prognosis that can have widespread metastases at presentation." | ( Bal, A; Dey, P; Jung, RS; Kapoor, R; Mittal, BR; Shukla, J, 2015) |
| "Malignant melanoma is a destructive and lethal form of skin cancer with poor prognosis." | ( Aziz, F; Liu, JW; Shan, X; Tian, LL; Wang, XQ; Yan, Q, 2015) |
| "Malignant melanoma is a melanocytic tumor with a high potential of invasion and metastasis." | ( Li, YQ; Lv, YT; Wang, JM; Zhang, YP, 2015) |
| "Malignant melanoma is a highly aggressive form of skin cancer with a high mortality rate if not discovered in early stages." | ( Faião-Flores, F; Fruet, AC; Maria, DA; Maria-Engler, SS; Pardi, PC; Quincoces Suarez, JA, 2015) |
| "Early diagnosis of malignant melanoma is important for patient survival." | ( Chang, CC; Chang, CH; Chen, CL; Lin, MH; Liu, RS; Shen, CC; Wang, HE, 2015) |
| "Malignant melanoma is a highly aggressive cancer, and the incidence of this disease is increasing worldwide at an alarming rate." | ( Anderson, CJ; Beaino, W; Nedrow, JR, 2015) |
| "Malignant melanoma is the most dangerous type of skin cancer." | ( Arnér, ES; Brodin, B; Campbell, J; Drummond, CJ; Higgins, M; Laín, S; McCarthy, AR; Sachweh, MC; Stafford, WC, 2015) |
| "Malignant melanoma is a highly aggressive tumor which may occur in the skin, eye, and mucous membranes." | ( Agliano, F; Morabito, S; Oteri, R; Teti, D; Venza, I; Venza, M; Visalli, M, 2015) |
| "Malignant melanoma is a type of skin cancer with accelerated evolution and a high metastatic potential, thus being the most aggressive type of skin tumor." | ( Blendea, A; Brănişteanu, DE; Costache, A; Georgescu, CV; Ţolea, I, 2015) |
| "The incidence of malignant melanoma is increasing, and up to 5 % of patients will experience in-transit metastases." | ( Bagge, AS; Belgrano, V; Ben-Shabat, I; Olofsson Bagge, R, 2016) |
| "Malignant melanoma is an aggressive, highly lethal dermatological malignancy." | ( Chen, YP; Feng, SX; Hou, XY; Jiang, G; Jiang, XX; Liu, YQ; Xu, XF; Yang, CS; Yang, M, 2016) |
| "Malignant melanoma is an aggressive tumor of the skin and seems to be resistant to current therapeutic approaches." | ( Candido, S; Cavalieri, S; Libra, M; McCubrey, JA; Motta, S; Nicoletti, F; Pappalardo, F; Pennisi, M; Russo, G, 2016) |
| "Malignant melanoma is the leading cause of death from skin cancer." | ( Beretta, G; Casati, L; Comitato, R; Festuccia, C; Gravina, GL; Limonta, P; Marzagalli, M; Montagnani Marelli, M; Moretti, RM, 2016) |
| "Malignant melanoma is the most aggressive form of skin carcinoma, which possesses fast propagating and highly invasive characteristics." | ( Guo, G; Mei, Z; Niu, T; Tian, Y, 2016) |
| "Malignant melanoma is one of the most dangerous skin cancer originating from melanocytes." | ( Kobiela, T; Lekka, M; Milner-Krawczyk, M; Sobiepanek, A, 2017) |
| "Malignant melanoma is a fast growing form of skin cancer with increasing global incidence." | ( Finocchiaro, LME; Glikin, GC; Rossi, UA, 2017) |
| "Incidence of malignant melanoma is increasing globally." | ( Dvořánková, B; Kodet, O; Kolář, M; Krejčí, E; Lacina, L; Naňka, O; Šedo, A; Smetana, K; Strnad, H; Szabo, P, 2017) |
| "Cutaneous malignant melanoma is among the deadliest human cancers, broadly resistant to most clinical therapies." | ( Merlino, G; Mishra, PJ, 2016) |
| "Malignant melanoma is a highly aggressive tumor resistant to chemotherapy." | ( Guo, XL; Jiang, BP; Liang, H; Shen, XC; Wang, Y; Zhang, L; Zhu, Y, 2017) |
| "Malignant melanoma is the deadliest form of all skin cancers." | ( Li, D; Liang, G; Liu, M; Liu, W; Mei, H; Shen, Y; Wang, Q, 2017) |
| "Malignant melanoma is a highly aggressive neoplasia of melanocytic origin." | ( Hu, G; Jiang, MJ; Li, FJ; Li, LM; Long, J; Xu, C; Zhang, RH; Zhou, P, 2017) |
| "Malignant melanoma is the most invasive and fatal form of cutaneous cancer." | ( Cheng, W; Han, X; Lin, J; Ni, J; Song, Z; Zhang, Y; Zhao, G, 2017) |
| "Malignant melanoma is a lethal form of skin cancer and highly metastatic tumor with poor prognosis; BEL β-trefoil, a lectin, obtained by our group, possesses the ability to act specifically on malignant cells." | ( Bovi, M; Cavallini, C; Cheri, S; Dalle Carbonare, L; Innamorati, G; Mori, A; Perduca, M; Scupoli, MT; Valenti, MT, 2017) |
| "Anorectal malignant melanoma is often misdiagnosed as either hemorrhoids or benign anorectal conditions in inflammatory bowel disease." | ( Kim, SE; Moon, W; Park, MI; Park, SJ; Seo, KI, 2017) |
| "Stage III malignant melanoma is a heterogeneous disease where those cases deemed marginally resectable or irresecatble are frequently incurable by surgery alone." | ( Ben-Ami, E; Ben-Betzalel, G; Goitein, D; Markel, G; Nissan, A; Schachter, J; Schneebaum, S; Shapira-Frommer, R; Zippel, D, 2017) |
| "Malignant melanoma is the most dangerous form of skin cancer, with a rapidly increasing incidence rate." | ( Carsten, B; Dyshlovoy, SA; Ermakova, SP; Gunhild, VA; Ivanchina, NV; Kicha, AA; Malyarenko, OS; Malyarenko, TV; Stonik, VA, 2017) |
| "Malignant melanoma is one of the most common malignant diseases of the gastrointestinal tract." | ( Choi, CW; Kang, DH; Kim, HJ; Kim, HW; Kim, SJ; Lee, JS; Park, SB; Yeo, CW, 2017) |
| "Malignant melanoma is the leading cause of mortality among the skin‑associated diseases because of its highly metastatic nature and lethality." | ( Li, TH; Yan, HX, 2018) |
| "Malignant melanoma is highly metastatic, and melanoma patients can develop chemotherapeutic resistance against conventional melanoma therapies." | ( Choi, KC; Heo, JR; Hwang, KA; Kim, GS; Lee, GA, 2018) |
| "Malignant melanoma is among the most aggressive cancers and its incidence is increasing worldwide." | ( Borgognoni, L; Deng, X; Gagliardi, S; Gray, NS; Pandolfi, S; Rovida, E; Stecca, B; Tubita, A; Tusa, I; Urso, C; Wang, J, 2018) |
| "Malignant melanoma is a devastating skin cancer due to its severe drug resistance and prompt metastasis." | ( Gao, T; Lei, Q; Song, X; Xiong, J; Yao, Y; Zhang, L, 2018) |
| "Malignant melanoma is an important type of cancer worldwide due to its aggressiveness and poor survival rate." | ( Antony, LP; Calcagno, DQ; de Arruda Cardoso Smith, M; de Lucas Chazin, E; de Vasconcellos, MC; do Nascimento Pedrosa, T; Dos Santos Barbosa, G; Montenegro, RC; Ralph, ACL; Vasconcelos, TRA; Vasconcelos, ZS, 2018) |
| "Malignant melanoma is the most commonly diagnosed skin cancer associated with a high rate of metastasis." | ( Kalafatis, M; Manouchehri, JM; Turner, KA, 2018) |
| "Malignant melanoma is an agressive tumour related to the overproduction of melanin, which provides colors of skin, eyes and hair." | ( Aytemir, MD; Ercan, A; Karakaya, G; Oncul, S, 2018) |
| "Malignant melanomas are amongst the most aggressive cancers." | ( Bu, CN; Dong, YL; Li, QS; Lin, MX; Ruan, BF; Shao, Q; Wang, TH; Xu, HJ; Zhang, Q; Zhou, BG, 2018) |
| "The incidence of malignant melanoma is increasing." | ( Abramov, I; Khochenkov, D; Prokofieva, A; Ryabaya, O; Stepanova, E; Zasedatelev, A, 2018) |
| "Malignant melanoma is an aggressive form of cancer which is highly resistant to chemotherapy." | ( Gao, Y; Liang, L; Liu, J; Qin, X; Zeng, W; Zhang, Z; Zhao, P, 2018) |
| "Malignant melanoma is developed from pigment-containing cells, melanocytes, and primarily found on the skin." | ( Chi, PL; Chiang, YC; Hsu, LF; Ko, HH; Ko, MI; Lee, CW; Lee, MH; Peng, KT; Tsai, CL, 2018) |
| "Malignant melanoma is a highly aggressive form of skin cancer responsible for the majority of skin cancer-related deaths." | ( Agostinis, P; Alexopoulos, LG; Antoranz, A; Guttà, C; Kulms, D; Pliaka, V; Podder, B; Rehm, M; Rožanc, J; Rufo, N; Sakellaropoulos, T; Sauter, T; Vetma, V, 2019) |
| "Malignant melanoma is an aggressive skin cancer with limited therapeutic options." | ( de Carvalho Lima, EN; Maria, DA; Piqueira, JRC, 2018) |
| "Malignant melanoma is very rare in childhood." | ( Büyükkapu Bay, S; Kebudi, R; Zülfikar, B, 2019) |
| "Malignant melanoma is a highly lethal disease, and advanced stages of melanoma have proven to be resistant to many chemotherapeutic drugs including temozolomide and paclitaxel." | ( Han, B; Sun, B; Wang, YB, 2018) |
| "BACKGROUND Malignant melanoma is recalcitrant to most existing chemotherapies, and aberrant expression of miR-211 plays prominent roles in progression of melanoma." | ( Lee, D; Li, N; Liu, Y; Pang, H; Xiao, Z; Zhou, Y, 2019) |
| "Malignant melanoma is a highly aggressive skin cancer that is highly resistant to chemotherapy." | ( Aizawa, S; Hara, H; Harada, T; Makita, K; Nakayama, T; Ochiai, Y; Okamoto, Y; Sano, E; Ueda, T; Yoshino, A, 2019) |
| "Malignant melanoma is the deadliest form of skin cancer and highly chemoresistant." | ( Baek, SB; Jung, HJ; Lim, HN, 2019) |
| "Malignant melanoma is a highly aggressive skin cancer and metastases rapidly extend to the regional lymph nodes (stage 3) and to distal organs (stage 4)." | ( Appelqvist, R; Baldetorp, B; Berge, E; Betancourt, LH; Burestedt, E; Corthals, G; Doma, V; Eriksson, J; Gil, J; Horvath, Z; Horvatovich, P; Ingvar, C; Jönsson, G; Karpati, S; Kim, Y; Knudsen, B; Kuras, M; Kwon, HJ; Lee, B; Lindberg, H; Lundgren, L; Malm, J; Marko-Varga, G; Miliotis, T; Murillo, JR; Németh, IB; Nishimura, T; Olsson, H; Oskolas, H; Pawłowski, K; Pla, I; Rezeli, M; Sanchez, A; Sugihara, Y; Szasz, AM; Timar, J; Welinder, C; Wieslander, E, 2019) |
| "Malignant melanoma is one of the most difficult cancers to treat due to its resistance to chemotherapy." | ( Arulananda, S; Behren, A; Cebon, J; Dobrovic, A; Evangelista, M; Fairlie, WD; Gunasingh, G; Haass, NK; Harris, TJ; Herold, MJ; Hobbs, C; John, T; Lee, EF; Mariadason, JM; Ramnac, C; Rohrbeck, L; Segal, D; Strasser, A; Tran, S; Zhu, H, 2019) |
| "Human malignant melanoma is one of the most aggressive cancers, accompanied with poor prognosis, metastatic evolution and high mortality." | ( Fasoli, S; Gotte, G; Menegazzi, M; Prodomini, S; Raineri, A, 2019) |
| "Malignant melanoma is the leading cause of death from skin disease, due in large part to its propensity to metastasize." | ( Li, CY; Li, G; Shen, S; Wang, Q; Wang, X; Wei, X, 2019) |
| "Malignant melanoma is a rare disease in the pediatric population and there are no recommendations regarding its management in children, while the current standard of care in metastatic or unresectable melanoma in adult patients includes immunotherapy (anti-CTLA-4 and anti-PD-1 antibodies)." | ( Galazka, P; Marjanska, A; Marjanski, M; Styczynski, J; Wysocki, M, 2019) |
| "Malignant melanoma is the most aggressive and lethal form of skin cancer." | ( Chodurek, E; Pilawa, B; Zdybel, M, 2019) |
| "Malignant melanoma is a high aggressive malignancy in humans and causes 60-80% of deaths from skin cancer." | ( Beberok, A; Respondek, M; Rok, J; Rzepka, Z; Wrześniok, D, 2020) |
| "Malignant melanoma is the most aggressive type of skin cancer and is closely associated with the development of brain metastases." | ( Aasen, SN; Bjerkvig, R; Feng, Z; Hoang, T; Knappskog, S; Parajuli, H; Roy, K; Stokke, K; Thorsen, F; Wang, J, 2019) |
| "Malignant melanoma is an aggressive type of cancer and the deadliest form of skin cancer." | ( Aplak, E; Berning, L; Brenneisen, P; Reichert, AS; Scharf, L; Stahl, W; Stucki, D; von Montfort, C, 2019) |
| "Malignant melanoma is one of the most leading forms of skin cancer associated with a low patient survival rate." | ( Fan, P; Fang, M; Li, Z; Zuo, C, 2020) |
| "Malignant melanoma is the most aggressive form of skin cancer; a substantial percentage of patients present with distant metastases." | ( Hong, J; Oh, E; Yun, CO, 2019) |
| "Cutaneous malignant melanoma is a neoplasm whose incidence and mortality are dramatically increasing." | ( Baldari, S; Baratto, L; Iagaru, A; Laudicella, R; Minutoli, F, 2020) |
| "Malignant melanoma is an aggressive skin cancer with poor survival outcomes for patients diagnosed at an advanced stage." | ( Burnett, K; Callan, B; Callan, JF; Dhillon, SK; Matin, RN; McHale, AP; McKaig, T; Nesbitt, H; Porter, SL; Rizk, N; Sheng, Y; White, B, 2020) |
| "Malignant melanoma is the most aggressive form of skin cancer, and once it becomes metastatic the prognosis is very poor." | ( Aplak, E; Brenneisen, P; Haasler, L; Reichert, AS; Stahl, W; Steckel, B; Stucki, D; von Montfort, C, 2020) |
| "Malignant melanoma is one of the most invasive tumours." | ( Chen, X; Guo, J; Liang, L; Liu, H; Liu, J; Liu, N; Peng, C; Qi, M; Su, J; Zhang, J; Zhao, S, 2020) |
| "Malignant melanoma is a devastating disease." | ( Alimohammadi, M; Bekeschus, S; Golpur, M; Hadavi, S; Niaki, HA; Rafiei, A; Sohbatzadeh, F; Valadan, R, 2020) |
| "Malignant melanoma is an emerging problem worldwide due to the high degree of lethalness." | ( Brzózka, Z; Chudy, M; Lamch, Ł; Piechota, B; Tokarska, K; Wilk, KA; Żukowski, K, 2020) |
| "Malignant melanoma is a kind of highly invasive and deadly diseases." | ( Chen, Y; Li, X; Liu, X; Rao, M; Shi, B; Sun, X; Wang, Y; Yuan, Y; Zhang, M, 2020) |
| "Malignant melanoma is a common form of skin cancer that contains different cell types recognized by various cell surface markers." | ( Jobani, BM; Mohebi, E; Najafzadeh, N, 2020) |
| "Malignant melanoma is the deadliest skin cancer, due to its propensity to metastasize." | ( Allegra, M; Busà, R; De Cicco, P; Ercolano, G; Formisano, C; Ianaro, A; Taglialatela-Scafati, O, 2021) |
| "Malignant melanoma is the most aggressive form of skin cancer with high metastatic capacity." | ( Benedicto, A; Hernandez-Unzueta, I; Márquez, J; Sanz, E, 2021) |
| "Malignant melanoma is a life-threatening form of skin cancer with a low response rate to single-agent chemotherapy." | ( Chen, S; Liu, C; Song, M; Tao, Z; Xia, W; Zhang, W; Zhu, B, 2021) |
| "Malignant melanoma is a critical and aggressive skin tumor with a steeply rising incidence and a less favorable prognosis due to the lack of efficient treatment." | ( Fang, J; Huang, X; Liang, X; Liu, J; Wang, X; Yang, Y, 2021) |
| "Canine malignant melanoma is highly aggressive and generally chemoresistant." | ( Bonkobara, M; Kurita, S; Michishita, M; Miyamoto, R; Nagashima, T; Noguchi, S; Tamura, K; Tani, H; Yayoshi, N, 2021) |
| "Malignant melanoma is one of the most devastating types of cancer with rapid relapse and low survival rate." | ( Hu, L; Li, Q; Liu, G; Mu, Z; Sun, F; Wu, X; Zhang, D; Zhang, M; Zhang, W, 2021) |
| "Malignant melanoma is a well-known diagnostic pitfall, given its propensity to metastasize to different sites and mimic various entities." | ( Lajara, S; Landau, M, 2021) |
| "Malignant melanoma is a highly aggressive skin cancer characterized by an elevated grade of tumor cell plasticity." | ( Andreucci, E; Biagioni, A; Bianchini, F; Calorini, L; Del Rosso, M; Fibbi, G; Fucci, L; Guida, M; Laurenzana, A; Margheri, F; Nediani, C; Peppicelli, S; Ruzzolini, J; Serrat, S, 2022) |
| "Malignant melanoma is considered the most aggressive skin carcinoma with invasive growth patterns." | ( Du, Y; Gu, Y; Jiang, L; Liu, J; Tang, X; Wu, X, 2021) |
| "Malignant melanoma is an aggressive tumor with a high potential for distant metastases." | ( Amaya, S; Minami, T; Mitsui, T; Munemoto, Y; Nakanuma, Y; Saito, K; Shimada, M; Takashima, Y; Terada, T; Yamagishi, Y, 2021) |
| "Malignant melanoma is responsible for the majority of skin cancer-related deaths." | ( Banach, K; Beberok, A; Kowalska, J; Rok, J; Rzepka, Z; Wrześniok, D, 2021) |
| "Malignant melanoma is the most aggressive of skin cancers and the 19th most common cancer worldwide, with an estimated age-standardized incidence rate of 2." | ( Abbatepaolo, C; Arezzo, F; Bellitti, E; Cazzato, G; Cimmino, A; Colagrande, A; Cormio, G; Foti, C; Ingravallo, G; Lettini, T; Loizzi, V; Lospalluti, L; Resta, L; Romita, P; Rossi, R; Sablone, S, 2021) |
| "Malignant melanoma is rare in the pediatric population and management is largely extrapolated from adult guidelines." | ( Aldrink, JH; Baertschiger, RM; Fahy, AS; Helenowski, I; Lautz, TB; Wayne, JD, 2022) |
| "Malignant melanoma is regarded as the most aggressive form of skin cancer, and is responsible for most death caused by skin cancer." | ( Bing, T; Chen, H; Jin, S; Li, W; Shangguan, D; Wang, R, 2021) |
| "Malignant melanoma is the deadliest form of skin cancer and NRF2 has been proposed as a main regulator of tumor cell malignancy." | ( Depke, M; Gschwendtner, A; Hengstschläger, M; Hundsberger, H; Mikula, M; Schmidt, F; Trautinger, F; Weitzenböck, HP; Wiesner, C, 2022) |
| "Cutaneous malignant melanoma is the fastest growing and the most aggressive form of skin cancer that is diagnosed." | ( Juszczak, AM; Končić, MZ; Tomczyk, M; Wöelfle, U, 2022) |
| "Malignant melanoma is an aggressive and deadly form of skin cancer and novel and improved therapeutic options are needed." | ( Albino, M; Correia, I; Côrte-Real, L; Gaspar, MM; Lopes, J; Matos, CP; Mendes, F; Pessoa, JC; Reis, CP; Tomaz, AI; Viana, AS, 2022) |
| "Malignant melanoma is a malignant tumor with a poor prognosis." | ( Di Guardo, L, 2022) |
| "Malignant melanoma is an aggressive skin tumor with a rapidly increasing incidence and there is not yet a successful treatment strategy." | ( Aras, S; Cansaran-Duman, D; Eskiler, GG; Yangın, S, 2022) |
| "Cutaneous malignant melanoma is fastest-growing cancer in white populations with a large majority of dermal cancer death." | ( Abdi, F; Arkan, E; Eidizadeh, M; Gamizgy, YH; Mansouri, K; Naseriyeh, T; Valipour, E, 2023) |
| "Early diagnosis of malignant melanoma is critical for effective treatment and reduced patient mortality." | ( Hara, H; Harada, T; Hirai, S; Katoh, Y, 2022) |
| "Malignant melanoma is among the tumor entities with the highest increase of incidence worldwide." | ( Benz, F; Groeber-Becker, FK; Junger, C; Leikeim, A; Monaghan, MG; Neto, NGB; Schilling, B; Schmidt, FF; Tiltmann, K; Wußmann, M, 2022) |
| "Malignant melanoma is a skin cancer characterized by rapid development, poor prognosis and high mortality." | ( Góralczyk, A; Grabarska, A; Marzęda, P; Wróblewska-Łuczka, P; Łuszczki, JJ, 2022) |
| "Malignant melanoma is an aggressive skin cancer, accounting for the majority of skin cancer deaths." | ( Leenutaphong, P; Nararatwanchai, T; Phetchengkao, W; Poommarapan, K; Rummaneethorn, P; Srihirun, S; Srisubat, A; Suriyachan, K; Suwanpidokkul, N; Tancharoen, S, 2023) |
| "Malignant melanoma is considered a deadly aggressive form of skin cancer that frequently metastasizes to various distal organs, which harbors mutations of the BRAF or NRAS which occur in 30 to 50% of melanoma patients." | ( Godugu, C; Nagula, S; Pooladanda, V; Thatikonda, S; Tokala, R, 2023) |
| "(1) Malignant melanomas are dangerous skin cancers, and the treatment of melanomas with various cytostatic drugs often causes side effects and after their prolonged use resistance to these drugs appears." | ( Góralczyk, A; Wróblewska-Łuczka, P; Łuszczki, JJ, 2023) |
| "Malignant melanoma is one of the most aggressive and lethal skin cancer." | ( Ding, C; Ge, X; Jiang, J; Li, S; Li, Y; Qiao, Y; Wang, D; Wang, M; Wang, Y; Zheng, X, 2023) |
| "Malignant melanoma is challenging to treat, and metastatic cases need chemotherapy strategies." | ( Cserepes, M; Kigyós, A; Ladányi, A; Surguta, SE; Tóvári, J; Vári-Mező, D, 2023) |
| "Malignant melanoma is a dangerous skin cancer, accounting for the majority of skin cancer-related deaths." | ( Wilanowski, T; Wnuk, J, 2023) |